• $913.00
    Market Cap
  • -99.75%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: N/A
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.000001
$0.000001
$0.000001
1-Year Range
$0.000001
$0.002
$0.000001
Latest Close$0.000001
Change
$0.00 (0.00%)
Volume44,256
Market Cap$913.00
Shares Outstanding913.9M
P/E (TTM)-0.00002
Diluted EPS (TTM)-$0.04
Enterprise Value$27.6M

Information as of 05/28/2026

Company Profile

4Front Ventures Corp.
https://4frontventures.com
$913.00
Market Cap
-$36.4M
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
7010 East Chauncey Lane, Phoenix, AZ, United States, 85054
602 428 5337

4Front Ventures Corp. engages in cultivating, processing, manufacturing, and sale of cannabis products in the United States. The company operates through three segments: Illinois, Massachusetts, and Corporate. It offers flower, pre-rolls, vaporizers, concentrates, edibles, tinctures and soft gels, capsules, and topicals, as well as provides a vertically integrated supply chain to serve both medical and recreational markets. The company owns, operates, and manages cultivation and manufacturing facilities and retail centers; sales CBD products to third-party consumers; leases real estate in the state of Washington; and engages in other corporate activities. 4Front Ventures Corp. was founded in 2011 and is based in Phoenix, Arizona.

Key Executives

  • Andrew Fisher Thut
  • Kristopher Tutundjian Krane
  • Christopher Wimmer
  • Michael Kronberg
  • Karl Chowscano

Current Ownership Distribution

  • Mutual Funds503.5M (40.41%)
  • Other457.9M (36.75%)
  • Insiders280.2M (22.48%)
  • Institutions4.4M (0.36%)